Table 1: Baseline characteristics

Variable Frequency (n=1022)
Sex
Female
Male
F:M ratio
n (%)
658 (64.4)
364 (35.6)
1.8:1
Age
Mean (SD)
Range
Years
37.8 (10.0)
18-77
Initial WHO stage,
I
II
III
IV
n (%)
249 (24.4)
299 (29.2)
326 (31.9)
148 (14.5)
CD4+ at initiation of therapy
Median (IQR)
cells/mm3
149 (55-248)
CD4+ at initiation
< 100
100-200
>200
n (%)
377 (36.9)
273 (26.7)
372 (36.3)